Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 233 | 246 | 3,536 | 710 | 762 |
| Gross Profit | 233 | 246 | 3,536 | 710 | 762 |
| Operating Expenses | 1,177 | 1,606 | 151 | 6,326 | 1,053 |
| Operating Income | -944 | -1,360 | 3,385 | -5,616 | -291 |
| Pre-tax Income | -944 | -1,360 | 3,385 | -5,616 | -291 |
| Net Income Continuous | -944 | -1,360 | 3,385 | -5,616 | -291 |
| Net Income | $-944 | $-1,360 | $3,385 | $-5,616 | $-291 |
| EPS Basic Total Ops | -0.32 | -0.48 | 1.20 | -1.96 | -0.12 |
| EPS Basic Continuous Ops | -0.33 | -0.48 | 1.20 | -1.96 | -0.12 |
| EPS Diluted Total Ops | -0.32 | -0.48 | 1.20 | -1.96 | -0.12 |
| EPS Diluted Continuous Ops | -0.33 | -0.48 | 1.20 | -1.96 | -0.12 |
| EBITDA(a) | $-900 | $-1,271 | $3,415 | $-5,559 | $-241 |